Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Adv Drug Deliv Rev. 2022 Feb 18;183:114172. doi: 10.1016/j.addr.2022.114172

Figure 2.

Figure 2.

Machine learning platforms are trained using physicochemical and biological features to predict the biodistribution of nanomedicines accurately. The generalization of the platform can promote optimization of the biological efficacy and improvements towards clinical translations of nanomedicines.